Epigenetics and mechanobiology in heart development and congenital heart disease

DK Jarrell, ML Lennon, JG Jacot - Diseases, 2019 - mdpi.com
Congenital heart disease (CHD) is the most common birth defect worldwide and the number
one killer of live-born infants in the United States. Heart development occurs early in …

A drive in SUVs: from development to disease

VK Rao, A Pal, R Taneja - Epigenetics, 2017 - Taylor & Francis
Progression of cells through distinct phases of the cell cycle, and transition into out-of-
cycling states, such as terminal differentiation and senescence, is accompanied by specific …

Recapitulation and reversal of schizophrenia-related phenotypes in Setd1a-deficient mice

J Mukai, E Cannavò, GW Crabtree, Z Sun… - Neuron, 2019 - cell.com
SETD1A, a lysine-methyltransferase, is a key schizophrenia susceptibility gene. Mice
carrying a heterozygous loss-of-function mutation of the orthologous gene exhibit alterations …

Histone methyltransferase G9a is required for cardiomyocyte homeostasis and hypertrophy

R Papait, S Serio, C Pagiatakis, F Rusconi, P Carullo… - Circulation, 2017 - Am Heart Assoc
Background: Correct gene expression programming of the cardiomyocyte underlies the
normal functioning of the heart. Alterations to this can lead to the loss of cardiac …

Discovery of novel substrate-competitive lysine methyltransferase G9a inhibitors as anticancer agents

Y Nishigaya, S Takase, T Sumiya… - Journal of Medicinal …, 2023 - ACS Publications
Identification of structurally novel inhibitors of lysine methyltransferase G9a has been a
subject of intense research in cancer epigenetics. Starting with the high-throughput …

Structure-based development of novel substrate-type G9a inhibitors as epigenetic modulators for sickle cell disease treatment

Y Nishigaya, S Takase, T Sumiya, T Sato… - Bioorganic & Medicinal …, 2024 - Elsevier
The discovery and development of structurally distinct lysine methyltransferase G9a
inhibitors have been the subject of intense research in epigenetics. Structure-based …

Histone variant H3. 3 mutations in defining the chromatin function in mammals

M Trovato, V Patil, M Gehre, KM Noh - Cells, 2020 - mdpi.com
The systematic mutation of histone 3 (H3) genes in model organisms has proven to be a
valuable tool to distinguish the functional role of histone residues. No system exists in …

G9a/GLP Modulators: Inhibitors to Degraders

A Mukherjee, T Suzuki - Journal of Medicinal Chemistry, 2025 - ACS Publications
Histone methylation, a crucial aspect of epigenetics, intricately involves specialized
enzymes such as G9a, a histone methyltransferase (HMT) catalyzing the methylation of …

Polycomb protein RYBP activates transcription factor Plagl1 during in vitro cardiac differentiation of mouse embryonic stem cells

S Henry, L Kokity, MK Pirity - Open Biology, 2023 - royalsocietypublishing.org
RING1 and YY1 binding protein (RYBP) is primarily known to function as a repressor being
a core component of the non-canonical polycomb repressive complexes 1 (ncPRC1s) …

Induced cardiomyocyte maturation: Cardiac transcription factors are necessary but not sufficient

S Dal-Pra, CP Hodgkinson, VJ Dzau - PLoS One, 2019 - journals.plos.org
The process by which fibroblasts are directly reprogrammed into cardiomyocytes involves
two stages; initiation and maturation. Initiation represents the initial expression of factors that …